DE60319269D1 - Pharmazeutische verwendungen von 2-substituierten 4-heteroarylpyrimidinen - Google Patents
Pharmazeutische verwendungen von 2-substituierten 4-heteroarylpyrimidinenInfo
- Publication number
- DE60319269D1 DE60319269D1 DE60319269T DE60319269T DE60319269D1 DE 60319269 D1 DE60319269 D1 DE 60319269D1 DE 60319269 T DE60319269 T DE 60319269T DE 60319269 T DE60319269 T DE 60319269T DE 60319269 D1 DE60319269 D1 DE 60319269D1
- Authority
- DE
- Germany
- Prior art keywords
- sub
- sup
- alkyl
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Lubricants (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0229581 | 2002-12-19 | ||
GBGB0229581.4A GB0229581D0 (en) | 2002-12-19 | 2002-12-19 | Use |
PCT/GB2003/005558 WO2004056368A1 (en) | 2002-12-19 | 2003-12-18 | Therapeutic applications of 2-substituted 4-heteroarylryrimidines |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60319269D1 true DE60319269D1 (de) | 2008-04-03 |
DE60319269T2 DE60319269T2 (de) | 2009-02-26 |
Family
ID=9949983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60319269T Expired - Fee Related DE60319269T2 (de) | 2002-12-19 | 2003-12-18 | Pharmazeutische verwendungen von 2-substituierten 4-heteroarylpyrimidinen |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050282843A1 (de) |
EP (1) | EP1572211B1 (de) |
JP (1) | JP2006515588A (de) |
CN (1) | CN100425239C (de) |
AT (1) | ATE386529T1 (de) |
AU (1) | AU2003292444A1 (de) |
BR (1) | BR0316703A (de) |
CA (1) | CA2502138A1 (de) |
DE (1) | DE60319269T2 (de) |
ES (1) | ES2300617T3 (de) |
GB (1) | GB0229581D0 (de) |
MX (1) | MXPA05006515A (de) |
NZ (1) | NZ539671A (de) |
WO (1) | WO2004056368A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0012528D0 (en) * | 2000-05-23 | 2000-07-12 | Univ Palackeho | Triterpenoid derivatives |
GB0219052D0 (en) * | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
GB0226583D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Compounds |
AU2004221881A1 (en) * | 2003-03-13 | 2004-09-30 | Vertex Pharmaceuticals Incorporated | Compositions useful as protein kinase inhibitors |
CN102977015B (zh) | 2003-06-06 | 2015-05-06 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性***中的用途 |
CA2542880A1 (en) | 2003-10-21 | 2005-05-12 | Cyclacel Limited | Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
GB0402653D0 (en) * | 2004-02-06 | 2004-03-10 | Cyclacel Ltd | Compounds |
GB0411791D0 (en) * | 2004-05-26 | 2004-06-30 | Cyclacel Ltd | Compounds |
MX2007002169A (es) | 2004-08-27 | 2007-08-14 | Cyclacel Ltd | Inhibidores de cdk de purina y pirimidina y su uso para el tratamiento de enfermedades inmunes. |
FR2881742B1 (fr) * | 2005-02-10 | 2007-09-07 | Aventis Pharma Sa | Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation |
EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
EP1928437A2 (de) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenese mittels muscarinrezeptormodulation |
US8492428B2 (en) | 2005-09-20 | 2013-07-23 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
DE102005048072A1 (de) * | 2005-09-24 | 2007-04-05 | Bayer Cropscience Ag | Thiazole als Fungizide |
UY29827A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | 2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones |
WO2007040436A1 (en) * | 2005-10-03 | 2007-04-12 | Astrazeneca Ab | Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
GB0520955D0 (en) * | 2005-10-14 | 2005-11-23 | Cyclacel Ltd | Compound |
GB0520958D0 (en) * | 2005-10-14 | 2005-11-23 | Cyclacel Ltd | Compound |
CA2625153A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
DE102006001161A1 (de) * | 2006-01-06 | 2007-07-12 | Qiagen Gmbh | Verfahren zum Nachweis von Cytosin-Methylierungen |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2382975A3 (de) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenese mittels Angiotensin-Modulation |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
GB0805477D0 (en) * | 2008-03-26 | 2008-04-30 | Univ Nottingham | Pyrimidines triazines and their use as pharmaceutical agents |
JP5524209B2 (ja) * | 2008-08-15 | 2014-06-18 | エヌサーティー・ファーマシューティカルズ・インコーポレーテッド | S−ニトロソグルタチオンレダクターゼのピロール阻害剤 |
WO2010019903A1 (en) | 2008-08-15 | 2010-02-18 | N30 Pharmaceuticals, Llc | Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
DK2318007T3 (da) | 2008-08-15 | 2013-03-25 | N30 Pharmaceuticals Inc | Nye pyrrol-inhibitorer af s-nitrosoglutathion-reduktase som terapeutiske midler |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US20120077813A1 (en) | 2009-04-15 | 2012-03-29 | Astrazeneca Ab | Imidazole Substituted Pyrimidines Useful in the Treatment of Glycogen Synthase Kinase-3 Related Disorders such as Alzheimer's Disease |
MY171483A (en) * | 2012-07-16 | 2019-10-15 | Fibrogen Inc | Process for making isoquinoline compounds |
WO2014199164A1 (en) * | 2013-06-12 | 2014-12-18 | Ampla Pharmaceuticals, Inc. | Diaryl substituted heteroaromatic compounds |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG47583A1 (en) * | 1986-01-13 | 1998-04-17 | American Cyanamid Co | 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines |
US5985935A (en) * | 1992-03-06 | 1999-11-16 | Statens Seruminstitut | Treatment and prophylaxis of diseases caused by parasites, or bacteria |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
CN1312807A (zh) * | 1998-06-19 | 2001-09-12 | 希龙公司 | 糖元合成酶激酶3的抑制剂 |
WO2001072745A1 (en) * | 2000-03-29 | 2001-10-04 | Cyclacel Limited | 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders |
MY130778A (en) * | 2001-02-09 | 2007-07-31 | Vertex Pharma | Heterocyclic inhibitiors of erk2 and uses thereof |
KR20030076688A (ko) * | 2001-02-20 | 2003-09-26 | 아스트라제네카 아베 | Gsk3-관련 장애의 치료를 위한 2-아릴아미노-피리미딘 |
GB0107901D0 (en) * | 2001-03-29 | 2001-05-23 | Cyclacel Ltd | Anti-cancer compounds |
DE60214703T2 (de) * | 2001-06-01 | 2007-09-13 | Vertex Pharmaceuticals Inc., Cambridge | Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen |
EP1430051B1 (de) * | 2001-09-28 | 2006-12-27 | Cyclacel Limited | N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamine als antiproliferative verbindungen |
GB0226582D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Anti-viral compounds |
GB0226583D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Compounds |
GB0315966D0 (en) * | 2003-07-08 | 2003-08-13 | Cyclacel Ltd | Compounds |
JP2007500178A (ja) * | 2003-07-30 | 2007-01-11 | サイクラセル・リミテッド | プロテインキナーゼ阻害剤としてのピリジニルアミノ−ピリミジン誘導体 |
WO2005012262A1 (en) * | 2003-07-30 | 2005-02-10 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
CA2542880A1 (en) * | 2003-10-21 | 2005-05-12 | Cyclacel Limited | Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
GB0328180D0 (en) * | 2003-12-04 | 2004-01-07 | Cyclacel Ltd | Combination |
MX2007002169A (es) * | 2004-08-27 | 2007-08-14 | Cyclacel Ltd | Inhibidores de cdk de purina y pirimidina y su uso para el tratamiento de enfermedades inmunes. |
-
2002
- 2002-12-19 GB GBGB0229581.4A patent/GB0229581D0/en not_active Ceased
-
2003
- 2003-12-18 CN CNB2003801046977A patent/CN100425239C/zh not_active Expired - Fee Related
- 2003-12-18 BR BR0316703-8A patent/BR0316703A/pt not_active IP Right Cessation
- 2003-12-18 NZ NZ539671A patent/NZ539671A/en unknown
- 2003-12-18 AT AT03768023T patent/ATE386529T1/de not_active IP Right Cessation
- 2003-12-18 EP EP03768023A patent/EP1572211B1/de not_active Expired - Lifetime
- 2003-12-18 ES ES03768023T patent/ES2300617T3/es not_active Expired - Lifetime
- 2003-12-18 JP JP2004561646A patent/JP2006515588A/ja active Pending
- 2003-12-18 CA CA002502138A patent/CA2502138A1/en not_active Abandoned
- 2003-12-18 MX MXPA05006515A patent/MXPA05006515A/es active IP Right Grant
- 2003-12-18 AU AU2003292444A patent/AU2003292444A1/en not_active Abandoned
- 2003-12-18 WO PCT/GB2003/005558 patent/WO2004056368A1/en active IP Right Grant
- 2003-12-18 DE DE60319269T patent/DE60319269T2/de not_active Expired - Fee Related
-
2005
- 2005-05-26 US US11/140,136 patent/US20050282843A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE386529T1 (de) | 2008-03-15 |
US20050282843A1 (en) | 2005-12-22 |
DE60319269T2 (de) | 2009-02-26 |
CN1720049A (zh) | 2006-01-11 |
CN100425239C (zh) | 2008-10-15 |
WO2004056368A1 (en) | 2004-07-08 |
EP1572211A1 (de) | 2005-09-14 |
BR0316703A (pt) | 2005-10-18 |
EP1572211B1 (de) | 2008-02-20 |
CA2502138A1 (en) | 2004-07-08 |
MXPA05006515A (es) | 2005-09-08 |
AU2003292444A1 (en) | 2004-07-14 |
GB0229581D0 (en) | 2003-01-22 |
JP2006515588A (ja) | 2006-06-01 |
NZ539671A (en) | 2007-04-27 |
ES2300617T3 (es) | 2008-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60319269D1 (de) | Pharmazeutische verwendungen von 2-substituierten 4-heteroarylpyrimidinen | |
RU2395500C2 (ru) | 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств | |
ATE300521T1 (de) | Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern | |
RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
ATE203524T1 (de) | Chinazolin-derivate | |
EA200600648A1 (ru) | Производные пурина, ингибирующие репликацию вич | |
HUP0100950A2 (hu) | Ciklusos aminovegyületek, alkalmazásuk gyógyászati készítmények előállítására és a vegyületeket tartalmazó gyógyászati készítmények | |
MXPA01006474A (es) | Derivados colquinol como agentes perjudiciales vasculares. | |
DK1119567T3 (da) | Quinazolinderivater | |
NO20065078L (no) | Inhaleringspulver formuleringer inneholdende enantiomerisk rene beta-agonister. | |
NO20050573L (no) | 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler | |
EA200400466A1 (ru) | Производные пиперазина с антагонистической активностью к рецептору ccr1 | |
WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
ATE419245T1 (de) | Cinnoline verbindungen | |
AP1564A (en) | Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use. | |
BR0012157A (pt) | Derivado de quinazolina, derivado de pirimidina, processo para a preparação de um derivado de quinazolina, composição farmacêutica, uso de um derivado de quinazolina, e, método para a prevenção ou tratamento de doenças ou condições médicas pela célula t um em animal de sangue quente em necessidade de tal tratamento | |
TR199701647A2 (xx) | �kame edilmi� purin t�revleri,bunlar�n imalat usul� | |
HUP0203739A2 (hu) | A hatos-gyűrűn helyettesített biciklikus imidazo-3-il-amin-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
RU2008143703A (ru) | ПРИМЕНЕНИЕ ИНГИБИТОРОВ c-Src В КОМБИНАЦИИ С ПИРИМИДИЛАМИНОБЕНЗАМИДОМ ДЛЯ ЛЕЧЕНИЯ ЛЕЙКОЗА | |
DK1057828T3 (da) | Orale trovafloxacin-suspensioner | |
RU2008127260A (ru) | Производные хиназолинона в качестве антагонистов ваниллоидов | |
WO2007120726B1 (en) | Compositions and methods related to rad51 inactivation in the treatment of neoplastic diseases, and especially cml | |
DK1228758T3 (da) | Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom | |
ATE361749T1 (de) | Benzthiazol-3 oxide zur behandlung von proliferativen störungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |